Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy

Lerato Hlaka; Michael-Jon Rosslee; Mumin Ozturk; Santosh Kumar; Suraj Parihar; Frank Brombacher; Abedawn Khalaf; Katharine Carter; Fraser Scott; Colin Suckling; Reto Guler

doi:10.1093/jac/dkx326

Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy

Lerato Hlaka, Michael-Jon Rosslee, Mumin Ozturk, Santosh Kumar, Suraj Parihar, Frank Brombacher, Abedawn Khalaf, Katharine Carter, Fraser Scott, Colin Suckling, Reto Guler

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

41 Downloads (Pure)

Abstract

The slow development of major advances in drug discovery for the treatment of Mycobacterium tuberculosis (Mtb) infection have led to a compelling need for evaluation of more effective drug therapies against tuberculosis. New classes of drugs are constantly being evaluated for anti-mycobacterial activity with currently a very limited number of new drugs approved for TB treatment. Minor Groove Binders (MGBs) have previously revealed promising anti-microbial activity against various infectious agents; however have not yet been screened against Mtb.

Original language	English
Pages (from-to)	3334–3341
Number of pages	8
Journal	Journal of Antimicrobial Chemotherapy
Volume	72
Issue number	12
Early online date	18 Sept 2017
DOIs	https://doi.org/10.1093/jac/dkx326
Publication status	Published - 1 Dec 2017

Keywords

drug discovery
minor groove binder
tuberculosis

Access to Document

10.1093/jac/dkx326

Hlaka-etal-JAC-2017-Evaluation-of-Minor-Groove-Binders-MGBs-as-novel-anti-mycobacterial-agentsAccepted author manuscript, 1.12 MB

Cite this

Hlaka, L., Rosslee, M-J., Ozturk, M., Kumar, S., Parihar, S., Brombacher, F., Khalaf, A., Carter, K., Scott, F., Suckling, C., & Guler, R. (2017). Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy. Journal of Antimicrobial Chemotherapy, 72(12), 3334–3341. https://doi.org/10.1093/jac/dkx326

@article{9cfb76deca014a50943b2cf72d87cc7c,

title = "Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy",

abstract = "The slow development of major advances in drug discovery for the treatment of Mycobacterium tuberculosis (Mtb) infection have led to a compelling need for evaluation of more effective drug therapies against tuberculosis. New classes of drugs are constantly being evaluated for anti-mycobacterial activity with currently a very limited number of new drugs approved for TB treatment. Minor Groove Binders (MGBs) have previously revealed promising anti-microbial activity against various infectious agents; however have not yet been screened against Mtb. ",

keywords = "drug discovery, minor groove binder, tuberculosis",

author = "Lerato Hlaka and Michael-Jon Rosslee and Mumin Ozturk and Santosh Kumar and Suraj Parihar and Frank Brombacher and Abedawn Khalaf and Katharine Carter and Fraser Scott and Colin Suckling and Reto Guler",

note = "This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Antimicrobial Chemotherapy following peer review. The version of record Hlaka, L., Rosslee, M-J., Ozturk, M., Kumar, S., Parihar, S., Brombacher, F., ... Guler, R. (2017). Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy. Journal of Antimicrobial Chemotherapy, 72(12), 3334–3341, is available online at: https://doi.org/10.1093/jac/dkx326. ",

year = "2017",

month = dec,

day = "1",

doi = "10.1093/jac/dkx326",

language = "English",

volume = "72",

pages = "3334–3341",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "12",

}

Hlaka, L, Rosslee, M-J, Ozturk, M, Kumar, S, Parihar, S, Brombacher, F, Khalaf, A, Carter, K , Scott, F , Suckling, C & Guler, R 2017, 'Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy', Journal of Antimicrobial Chemotherapy, vol. 72, no. 12, pp. 3334–3341. https://doi.org/10.1093/jac/dkx326

Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy. / Hlaka, Lerato; Rosslee, Michael-Jon; Ozturk, Mumin et al.

In: Journal of Antimicrobial Chemotherapy, Vol. 72, No. 12, 01.12.2017, p. 3334–3341.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy

AU - Hlaka, Lerato

AU - Rosslee, Michael-Jon

AU - Ozturk, Mumin

AU - Kumar, Santosh

AU - Parihar, Suraj

AU - Brombacher, Frank

AU - Khalaf, Abedawn

AU - Carter, Katharine

AU - Scott, Fraser

AU - Suckling, Colin

AU - Guler, Reto

N1 - This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Antimicrobial Chemotherapy following peer review. The version of record Hlaka, L., Rosslee, M-J., Ozturk, M., Kumar, S., Parihar, S., Brombacher, F., ... Guler, R. (2017). Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy. Journal of Antimicrobial Chemotherapy, 72(12), 3334–3341, is available online at: https://doi.org/10.1093/jac/dkx326.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The slow development of major advances in drug discovery for the treatment of Mycobacterium tuberculosis (Mtb) infection have led to a compelling need for evaluation of more effective drug therapies against tuberculosis. New classes of drugs are constantly being evaluated for anti-mycobacterial activity with currently a very limited number of new drugs approved for TB treatment. Minor Groove Binders (MGBs) have previously revealed promising anti-microbial activity against various infectious agents; however have not yet been screened against Mtb.

AB - The slow development of major advances in drug discovery for the treatment of Mycobacterium tuberculosis (Mtb) infection have led to a compelling need for evaluation of more effective drug therapies against tuberculosis. New classes of drugs are constantly being evaluated for anti-mycobacterial activity with currently a very limited number of new drugs approved for TB treatment. Minor Groove Binders (MGBs) have previously revealed promising anti-microbial activity against various infectious agents; however have not yet been screened against Mtb.

KW - drug discovery

KW - minor groove binder

KW - tuberculosis

UR - https://academic.oup.com/jac

U2 - 10.1093/jac/dkx326

DO - 10.1093/jac/dkx326

M3 - Article

SN - 0305-7453

VL - 72

SP - 3334

EP - 3341

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 12

ER -

Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Katharine Carter

Fraser Scott

Cite this

Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents, and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Profiles

Katharine Carter

Fraser Scott

Cite this